Mainsail Asset Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$590K Sell
510
-13
-2% -$15.3K 0.24% 44
2026
Q2
$616K Sell
523
-1
-0.2% -$1.02K 0.24% 52
2026
Q1
$482K Buy
524
+259
+98% +$263K 0.22% 45
2025
Q4
$285K Sell
265
-149
-36% -$142K 0.12% 66
2025
Q3
$316K Buy
+414
New +$308K 0.14% 60

Other funds holding LLY

Mainsail Asset Management's LLY Position: Q3 2026 in Review

Mainsail Asset Management reduced its Eli Lilly (LLY) stake by 2.5% in Q3 2026, selling an estimated $15.3K and leaving 510 shares worth $590K. The position accounts for 0.24% of the portfolio, ranked #44.

Mainsail Asset Management first reported a position in LLY in Q3 2025 and has held it in 5 quarters since. The position peaked at $616K in Q2 2026. 4,624 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Mainsail Asset Management held 510 shares of Eli Lilly worth $590K as of Q3 2026.
  • Mainsail Asset Management sold 13 Eli Lilly shares in Q3 2026, an estimated $15.3K.
  • Eli Lilly made up 0.24% of Mainsail Asset Management's portfolio in Q3 2026, its #44 holding.
  • Mainsail Asset Management first reported a position in Eli Lilly in Q3 2025 and has held it in 5 quarters since.
  • Mainsail Asset Management's Eli Lilly position peaked at $616K in Q2 2026.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Mainsail Asset Management's 13F filing for Q3 2026, filed 14 Oct 2026.